| scholarly article | Q13442814 |
| P356 | DOI | 10.1038/NG0796-325 |
| P698 | PubMed publication ID | 8673132 |
| P2093 | author name string | Tran K | |
| Smith DB | |||
| Reddy S | |||
| Cros D | |||
| Davis BM | |||
| Balice-Gordon RJ | |||
| Housman D | |||
| Bronson R | |||
| Rich MM | |||
| Reilly P | |||
| Leferovich JM | |||
| Rayburn H | |||
| P2860 | cites work | A novel human muscle factor related to but distinct from MyoD1 induces myogenic conversion in 10T1/2 fibroblasts | Q24339468 |
| Expression and DNA sequence analysis of a human embryonic skeletal muscle myosin heavy chain gene | Q24339562 | ||
| The protein kinase family: conserved features and deduced phylogeny of the catalytic domains | Q27860528 | ||
| A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. | Q27860836 | ||
| The Haw River syndrome: dentatorubropallidoluysian atrophy (DRPLA) in an African-American family | Q28240104 | ||
| Unstable expansion of CAG repeat in hereditary dentatorubral-pallidoluysian atrophy (DRPLA) | Q28250990 | ||
| Differential expression of myogenic determination genes in muscle cells: possible autoactivation by the Myf gene products | Q28259742 | ||
| Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome | Q28273791 | ||
| Myotonic dystrophy mutation: an unstable CTG repeat in the 3' untranslated region of the gene | Q28285882 | ||
| Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene | Q28512170 | ||
| X chromosome-linked muscular dystrophy (mdx) in the mouse | Q28589078 | ||
| Disruption of the proto-oncogene int-2 in mouse embryo-derived stem cells: a general strategy for targeting mutations to non-selectable genes | Q29547355 | ||
| Expression of a single transfected cDNA converts fibroblasts to myoblasts | Q29547764 | ||
| Simplified mammalian DNA isolation procedure | Q29618648 | ||
| Coaxially stacked RNA helices in the catalytic center of the Tetrahymena ribozyme | Q30466252 | ||
| Contractile properties of muscles in myotonic dystrophy | Q33618940 | ||
| Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3' end of a transcript encoding a protein kinase family member. | Q33968674 | ||
| Quantitation of muscle precursor cell activity in skeletal muscle by Northern analysis of MyoD and myogenin expression: Application to dystrophic (mdx) mouse muscle | Q84900378 | ||
| Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy | Q34023072 | ||
| Full-length myotonin protein kinase (72 kDa) displays serine kinase activity | Q34215417 | ||
| Characterization of the myotonic dystrophy region predicts multiple protein isoform-encoding mRNAs | Q34231532 | ||
| Genomic organization and transcriptional units at the myotonic dystrophy locus | Q34321945 | ||
| Absence of myotonic dystrophy protein kinase (DMPK) mRNA as a result of a triplet repeat expansion in myotonic dystrophy | Q34348155 | ||
| Expansion of an unstable trinucleotide CAG repeat in spinocerebellar ataxia type 1. | Q34353488 | ||
| An unstable triplet repeat in a gene related to myotonic muscular dystrophy | Q34355359 | ||
| Decreased expression of myotonin-protein kinase messenger RNA and protein in adult form of myotonic dystrophy. | Q34363062 | ||
| A novel homeodomain-encoding gene is associated with a large CpG island interrupted by the myotonic dystrophy unstable (CTG)n repeat | Q34374463 | ||
| Dystrophin protects the sarcolemma from stresses developed during muscle contraction | Q36259954 | ||
| Genetic complementation reveals a novel regulatory role for 3' untranslated regions in growth and differentiation | Q36770883 | ||
| Electrophysiological study of dystrophia myotonica | Q37076001 | ||
| Sprouting and remodelling at the nerve-muscle junction | Q39746849 | ||
| Contractile properties and susceptibility to exercise-induced damage of normal and mdx mouse tibialis anterior muscle | Q41082867 | ||
| Anticipation in myotonic dystrophy: fact or fiction? | Q41231526 | ||
| Identification, Tissue-specific Expression, and Subcellular Localization of the 80- and 71-kDa Forms of Myotonic Dystrophy Kinase Protein | Q41302208 | ||
| Myopathology of myotonic dystrophy. A morphometric study | Q41598013 | ||
| Absence of expression of the FMR-1 gene in fragile X syndrome | Q41669091 | ||
| Identification of MRF4: a new member of the muscle regulatory factor gene family | Q41759866 | ||
| Fast and slow skeletal muscles: effect of ethanol on contractility of muscles from mice. | Q45968756 | ||
| Implications of FRA16A structure for the mechanism of chromosomal fragile site genesis | Q48081644 | ||
| Decreased myotonin-protein kinase in the skeletal and cardiac muscles in myotonic dystrophy | Q48089445 | ||
| Translational suppression by trinucleotide repeat expansion at FMR1. | Q52016323 | ||
| Trinucleotide repeat amplification and hypermethylation of a CpG island in FRAXE mental retardation. | Q52034632 | ||
| Course, prognosis and complications of childhood-onset myotonic dystrophy | Q52092992 | ||
| MyoD protein accumulates in satellite cells and is neurally regulated in regenerating myotubes and skeletal muscle fibers. | Q52209716 | ||
| Muscular dystrophy in the mdx mouse: histopathology of the soleus and extensor digitorum longus muscles. | Q52255659 | ||
| Expression of the proto-oncogene int-1 is restricted to postmeiotic male germ cells and the neural tube of mid-gestational embryos. | Q52255806 | ||
| Direct evidence that oncogenic tyrosine kinases and cyclic AMP-dependent protein kinase have homologous ATP-binding sites. | Q53551132 | ||
| Fetal myosin immunoreactivity in human dystrophic muscle | Q57973470 | ||
| (CTG)n Triplet Mutation and Phenotype Manifestations in Myotonic Dystrophy Patients | Q58194111 | ||
| Myotonic dystrophy: evidence for a possible dominant-negative RNA mutation | Q60050804 | ||
| Effect of Myotonic Dystrophy Trinucleotide Repeat Expansion on DMPK Transcription and Processing | Q62661555 | ||
| Identification of skeletal muscle precursor cells in vivo by use of MyoD1 and myogenin probes | Q67485917 | ||
| In vivo visualization of the growth of pre- and postsynaptic elements of neuromuscular junctions in the mouse | Q68453574 | ||
| Electron microscopic and autoradiographic characterization of hindlimb muscle regeneration in the mdx mouse | Q68529448 | ||
| Satellite cells as the source of nuclei in muscles of growing rats | Q70597273 | ||
| Embryonic and foetal myosins in human skeletal muscle. The presence of foetal myosins in duchenne muscular dystrophy and infantile spinal muscular atrophy | Q71008161 | ||
| Gain of glutamines, gain of function? | Q71990830 | ||
| Myotonic dystrophy: absence of CTG enlarged transcript in congenital forms, and low expression of the normal allele | Q72096934 | ||
| Expanded CTG triplet blocks from the myotonic dystrophy gene create the strongest known natural nucleosome positioning elements | Q72333265 | ||
| Abnormal sarcolemmal nuclei encountered in several cases of dystrophia myotonica | Q72399650 | ||
| Alterations of the Z-lines and I-band myofilaments in human skeletal muscle | Q72405661 | ||
| Identification and localization of the myotonic dystrophy gene product in skeletal and cardiac muscles | Q72767097 | ||
| Effect of the myotonic dystrophy (DM) mutation on mRNA levels of the DM gene | Q72896182 | ||
| P433 | issue | 3 | |
| P921 | main subject | myotonic dystrophy | Q1860507 |
| P304 | page(s) | 325-335 | |
| P577 | publication date | 1996-07-01 | |
| P1433 | published in | Nature Genetics | Q976454 |
| P1476 | title | Mice lacking the myotonic dystrophy protein kinase develop a late onset progressive myopathy | |
| P478 | volume | 13 |
| Q40971215 | (CTG)n repeats markedly inhibit differentiation of the C2C12 myoblast cell line: implications for congenital myotonic dystrophy |
| Q92827366 | AON-induced splice-switching and DMPK pre-mRNA degradation as potential therapeutic approaches for Myotonic Dystrophy type 1 |
| Q85711918 | Age-dependent chloride channel expression in skeletal muscle fibres of normal and HSA(LR) myotonic mice |
| Q52654324 | Altered nuclear structure in myotonic dystrophy type 1-derived fibroblasts. |
| Q24654728 | Altered phosphorylation and intracellular distribution of a (CUG)n triplet repeat RNA-binding protein in patients with myotonic dystrophy and in myotonin protein kinase knockout mice |
| Q36174612 | Altered β-adrenergic response in mice lacking myotonic dystrophy protein kinase |
| Q34219488 | Alternative splicing controls myotonic dystrophy protein kinase structure, enzymatic activity, and subcellular localization |
| Q33857850 | An untranslated CTG expansion causes a novel form of spinocerebellar ataxia (SCA8) |
| Q34608717 | Antisense therapy in neurology |
| Q101559243 | Application of CRISPR-Cas9-Mediated Genome Editing for the Treatment of Myotonic Dystrophy Type 1 |
| Q36060807 | Artificial mirtron-mediated gene knockdown: functional DMPK silencing in mammalian cells |
| Q42424866 | C9orf72 hexanucleotide repeat associated with amyotrophic lateral sclerosis and frontotemporal dementia forms RNA G-quadruplexes |
| Q35791378 | Changes in myotonic dystrophy protein kinase levels and muscle development in congenital myotonic dystrophy |
| Q52547985 | Characterization of cardiac conduction system abnormalities in mice with targeted disruption of Six5 gene. |
| Q74578232 | Clinical and genetic characteristics of a five-generation family with a novel form of myotonic dystrophy (DM2) |
| Q38209927 | Clinical aspects, molecular pathomechanisms and management of myotonic dystrophies |
| Q92255896 | Correction of RNA-Binding Protein CUGBP1 and GSK3β Signaling as Therapeutic Approach for Congenital and Adult Myotonic Dystrophy Type 1 |
| Q43987903 | Correction of dystrophia myotonica type 1 pre-mRNA transcripts by artificial trans-splicing |
| Q48726587 | Correlations between individual clinical manifestations and CTG repeat amplification in myotonic dystrophy |
| Q41002587 | DDX6 regulates sequestered nuclear CUG-expanded DMPK-mRNA in dystrophia myotonica type 1. |
| Q33842956 | DMPK dosage alterations result in atrioventricular conduction abnormalities in a mouse myotonic dystrophy model |
| Q74579021 | Decreased expression of myotonic dystrophy protein kinase and disorganization of sarcoplasmic reticulum in skeletal muscle of myotonic dystrophy |
| Q74609017 | Decreased levels of myotonic dystrophy protein kinase (DMPK) and delayed differentiation in human myotonic dystrophy myoblasts |
| Q37620767 | Deletion of the Ste20-like kinase SLK in skeletal muscle results in a progressive myopathy and muscle weakness |
| Q39728621 | Derivation, culture, and characterization of VUB hESC lines |
| Q48473616 | Developmental changes in expression of myotonic dystrophy protein kinase in the rat central nervous system |
| Q32062314 | Developmental regulation of myotonic dystrophy protein kinase in human muscle cells in vitro |
| Q36277192 | Diseases of unstable repeat expansion: mechanisms and common principles |
| Q41643458 | Dmpk gene deletion or antisense knockdown does not compromise cardiac or skeletal muscle function in mice |
| Q34252137 | Does (CUG)n repeat in DMPK mRNA 'paint' chromosome 19 to suppress distant genes to create the diverse phenotype of myotonic dystrophy?: A new hypothesis of long-range cis autosomal inactivation |
| Q92096984 | Dosage effect of multiple genes accounts for multisystem disorder of myotonic dystrophy type 1 |
| Q37713198 | Drosophila melanogaster As a Model Organism to Study RNA Toxicity of Repeat Expansion-Associated Neurodegenerative and Neuromuscular Diseases |
| Q73168300 | ETR-1, a homologue of a protein linked to myotonic dystrophy, is essential for muscle development in Caenorhabditis elegans |
| Q50133108 | Electrophysiological and histopathological findings of muscular disease suspected as myotonic dystrophy in a Shiba dog. |
| Q37695480 | Epigenetic changes and non-coding expanded repeats |
| Q36848454 | Epigenetics in nucleotide repeat expansion disorders |
| Q41392519 | Epigenetics of the myotonic dystrophy-associated DMPK gene neighborhood |
| Q77058046 | Evolution of simple repeats in DNA and their relation to human disease |
| Q34362347 | Expanded CUG repeat RNAs form hairpins that activate the double-stranded RNA-dependent protein kinase PKR |
| Q34142078 | Expanded CUG repeats trigger aberrant splicing of ClC-1 chloride channel pre-mRNA and hyperexcitability of skeletal muscle in myotonic dystrophy |
| Q36656342 | Expansion of a CUG trinucleotide repeat in the 3' untranslated region of myotonic dystrophy protein kinase transcripts results in nuclear retention of transcripts |
| Q48046904 | Expansion of the myotonic dystrophy CTG repeat reduces expression of the flanking DMAHP gene |
| Q74607477 | Fragile-X syndrome and myotonic dystrophy: parallels and paradoxes |
| Q40861559 | Gene disruption in mice: models of development and disease |
| Q41092886 | Genome Therapy of Myotonic Dystrophy Type 1 iPS Cells for Development of Autologous Stem Cell Therapy |
| Q39700299 | HTS-Compatible Patient-Derived Cell-Based Assay to Identify Small Molecule Modulators of Aberrant Splicing in Myotonic Dystrophy Type 1. |
| Q44420167 | Hammerhead ribozyme-mediated destruction of nuclear foci in myotonic dystrophy myoblasts |
| Q28585557 | Heterozygous loss of Six5 in mice is sufficient to cause ocular cataracts |
| Q28646933 | Homodimerization through coiled-coil regions enhances activity of the myotonic dystrophy protein kinase |
| Q35033174 | Hypothesis: neoplasms in myotonic dystrophy |
| Q36186164 | Identification and characterization of modified antisense oligonucleotides targeting DMPK in mice and nonhuman primates for the treatment of myotonic dystrophy type 1. |
| Q24328773 | Identification of a (CUG)n triplet repeat RNA-binding protein and its expression in myotonic dystrophy |
| Q35309394 | Lens epithelial changes and mutated gene expression in patients with myotonic dystrophy |
| Q33808904 | Long tract of untranslated CAG repeats is deleterious in transgenic mice |
| Q34142085 | Loss of the muscle-specific chloride channel in type 1 myotonic dystrophy due to misregulated alternative splicing |
| Q24310407 | MBNL1 associates with YB-1 in cytoplasmic stress granules |
| Q24315686 | MKBP, a novel member of the small heat shock protein family, binds and activates the myotonic dystrophy protein kinase |
| Q28504484 | Mice deficient in Six5 develop cataracts: implications for myotonic dystrophy |
| Q36640173 | Misregulation of alternative splicing causes pathogenesis in myotonic dystrophy. |
| Q71167684 | Model mice and human disease |
| Q64980454 | Modeling of Myotonic Dystrophy Cardiac Phenotypes in Drosophila. |
| Q41560194 | Molecular Effects of the CTG Repeats in Mutant Dystrophia Myotonica Protein Kinase Gene |
| Q24548314 | Molecular basis for impaired muscle differentiation in myotonic dystrophy |
| Q77810812 | Molecular basis of neuromuscular diseases |
| Q74458479 | Molecular biology of human arrhythmias: implications for the clinical electrophysiologist |
| Q38326275 | Molecular mechanisms in DM1 - a focus on foci. |
| Q57877560 | Mouse Models of Triplet Repeat Diseases |
| Q26798784 | Muscle wasting in myotonic dystrophies: a model of premature aging |
| Q36106234 | Muscleblind-Like 1 and Muscleblind-Like 3 Depletion Synergistically Enhances Myotonia by Altering Clc-1 RNA Translation |
| Q39533050 | Muscleblind-like 3 deficit results in a spectrum of age-associated pathologies observed in myotonic dystrophy |
| Q33548657 | Muscleblind1, but not Dmpk or Six5, contributes to a complex phenotype of muscular and motivational deficits in mouse models of myotonic dystrophy |
| Q34358301 | Mutant (CCTG)n Expansion Causes Abnormal Expression of Zinc Finger Protein 9 (ZNF9) in Myotonic Dystrophy Type 2 |
| Q35633172 | Myogenic defects in myotonic dystrophy |
| Q39012035 | Myotonic Dystrophy Type 2: An Update on Clinical Aspects, Genetic and Pathomolecular Mechanism |
| Q88453318 | Myotonic Dystrophy and Developmental Regulation of RNA Processing |
| Q37434343 | Myotonic dystrophy mouse models: towards rational therapy development. |
| Q73408342 | Myotonic dystrophy protein kinase (DMPK) induces actin cytoskeletal reorganization and apoptotic-like blebbing in lens cells |
| Q30009539 | Myotonic dystrophy protein kinase (DMPK) prevents ROS-induced cell death by assembling a hexokinase II-Src complex on the mitochondrial surface |
| Q24336794 | Myotonic dystrophy protein kinase is expressed in embryonic myocytes and is required for myotube formation |
| Q28588083 | Myotonic dystrophy protein kinase is involved in the modulation of the Ca2+ homeostasis in skeletal muscle cells |
| Q24321799 | Myotonic dystrophy protein kinase phosphorylates phospholamban and regulates calcium uptake in cardiomyocyte sarcoplasmic reticulum |
| Q41150528 | Myotonic dystrophy, knockouts, warts and all. |
| Q34446614 | Myotonic dystrophy--a multigene disorder. |
| Q41521385 | Myotonic dystrophy: Molecular and cellular consequences of expanded DNA repeats are elusive |
| Q35738537 | Myotonic dystrophy: RNA pathogenesis comes into focus |
| Q38855524 | Myotonic dystrophy: approach to therapy |
| Q34778128 | Myotonic dystrophy: clinical and molecular parallels between myotonic dystrophy type 1 and type 2. |
| Q34658838 | Myotonic dystrophy: molecular windows on a complex etiology |
| Q34068475 | Myotonic dystrophy: the role of RNA CUG triplet repeats |
| Q74057903 | Myotonic dystrophy: the role of the CUG triplet repeats in splicing of a novel DMPK exon and altered cytoplasmic DMPK mRNA isoform ratios |
| Q36638284 | Neurodegeneration the RNA way |
| Q35791191 | Neurodegenerative disorders associated with diabetes mellitus |
| Q43881510 | New theories. Causes of dilated cardiomyopathy |
| Q58698104 | Nuclear Envelope Transmembrane Proteins in Myotonic Dystrophy Type 1 |
| Q64989527 | Of Mice and Men: Advances in the Understanding of Neuromuscular Aspects of Myotonic Dystrophy. |
| Q41075540 | Overexpression of 3'-untranslated region of the myotonic dystrophy kinase cDNA inhibits myoblast differentiation in vitro |
| Q52540375 | Progressive atrioventricular conduction block in a mouse myotonic dystrophy model. |
| Q53944704 | Properties of Ca2+-activated K+ channels in erythrocytes from patients with myotonic muscular dystrophy. |
| Q37365699 | RNA metabolism in myotonic dystrophy: patient muscle shows decreased insulin receptor RNA and protein consistent with abnormal insulin resistance. |
| Q37216891 | RNA-mediated toxicity in neurodegenerative disease |
| Q34243144 | RNA-protein interactions in unstable microsatellite diseases. |
| Q37871417 | RNAi: a potential new class of therapeutic for human genetic disease |
| Q33907087 | Rac-1 and Raf-1 kinases, components of distinct signaling pathways, activate myotonic dystrophy protein kinase |
| Q89093199 | Recapitulating muscle disease phenotypes with myotonic dystrophy 1 induced pluripotent stem cells: a tool for disease modeling and drug discovery |
| Q24290177 | Recruitment of human muscleblind proteins to (CUG)(n) expansions associated with myotonic dystrophy |
| Q42566971 | Ribonuclear foci at the neuromuscular junction in myotonic dystrophy type 1. |
| Q41051948 | Ribozyme-mediated trans-splicing of a trinucleotide repeat. |
| Q33305207 | Role of myotonic dystrophy protein kinase (DMPK) in glucose homeostasis and muscle insulin action |
| Q92027741 | Short Tandem Repeat Expansions and RNA-Mediated Pathogenesis in Myotonic Dystrophy |
| Q42316379 | Sodium Channel Inhibitors Reduce DMPK mRNA and Protein |
| Q27654285 | Structure of dystrophia myotonica protein kinase |
| Q33752585 | Targeting DMPK with Antisense Oligonucleotide Improves Muscle Strength in Myotonic Dystrophy Type 1 Mice |
| Q33903996 | The 3' untranslated region of messenger RNA: A molecular 'hotspot' for pathology? |
| Q41477080 | The complex pathology of trinucleotide repeats |
| Q38045121 | The myotonic dystrophies: molecular, clinical, and therapeutic challenges |
| Q27025923 | The unstable repeats--three evolving faces of neurological disease |
| Q57113916 | Therapeutic Genome Editing for Myotonic Dystrophy Type 1 Using CRISPR/Cas9 |
| Q35924075 | Therapeutic impact of systemic AAV-mediated RNA interference in a mouse model of myotonic dystrophy. |
| Q36656460 | Transcriptional abnormality in myotonic dystrophy affects DMPK but not neighboring genes |
| Q34267388 | Transgenic mouse models for myotonic dystrophy type 1 (DM1) |
| Q41097952 | Trinucleotide repeat expansion at the myotonic dystrophy locus reduces expression of DMAHP. |
| Q24548860 | Visualization of double-stranded RNAs from the myotonic dystrophy protein kinase gene and interactions with CUG-binding protein |
| Q21142651 | ZNF9 activation of IRES-mediated translation of the human ODC mRNA is decreased in myotonic dystrophy type 2 |
Search more.